China Biologic Products Redomicile from Delaware to the Cayman Islands
Davis Polk advised China Biologic Products, Inc., a NASDAQ-listed company, in connection with its change of domicile from Delaware to the Cayman Islands by its merging with and into China Biologic Products Holdings, Inc., a wholly owned subsidiary of CBPO incorporated in the Cayman Islands, with CBPO Cayman surviving the merger and succeeding to all of China Biologic Products’s interests. Following the completion of the redomicile merger, CBPO Cayman qualifies as a foreign private issuer for U.S. securities law purposes and continues to be listed on NASDAQ under the same symbol.